Nice find. So their next study is going to address
Post# of 1460
(Total Views: 303)
Posted On: 08/03/2017 10:10:56 AM
Nice find. So their next study is going to address the safety concerns?
I think it was a mistake to have that arm that combined this drug with memantine. Memantine doesn't work all that well and has side effects of its own, and trying a new drug in combination with it -- which may have some kind of horrible interaction -- seems like a mistake.
It looks like this vTv company is not publicly traded. Is that correct?
Also -- for anyone wondering, it's perfectly fine to talk about Alzheimers' research companies other than AVXL. Our rules here about discussing other companies are much looser than other message boards.
I think it was a mistake to have that arm that combined this drug with memantine. Memantine doesn't work all that well and has side effects of its own, and trying a new drug in combination with it -- which may have some kind of horrible interaction -- seems like a mistake.
It looks like this vTv company is not publicly traded. Is that correct?
Also -- for anyone wondering, it's perfectly fine to talk about Alzheimers' research companies other than AVXL. Our rules here about discussing other companies are much looser than other message boards.
(0)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼